Potomac Capital Management’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$363K Buy
14,959
+7,500
+101% +$133K 0.42% 42
2023
Q3
$151K Hold
7,459
0.19% 45
2023
Q2
$220K Sell
7,459
-541
-7% -$15.4K 0.23% 55
2023
Q1
$200K Hold
8,000
0.21% 58
2022
Q4
$254K Buy
+8,000
New +$252K 0.3% 53
2022
Q2
Sell
-4,000
Closed -$540K 73
2022
Q1
$540K Hold
4,000
0.47% 49
2021
Q4
$521K Buy
+4,000
New +$506K 0.46% 52

Other funds holding LONA

Potomac Capital Management's LONA Position: Q4 2023 in Review

Potomac Capital Management increased its LeonaBio Inc (LONA) stake by 101% in Q4 2023, buying an estimated $133K and bringing the position to 14,959 shares worth $363K. The position accounts for 0.42% of the portfolio, ranked #42.

Potomac Capital Management first reported a position in LONA in Q4 2021 and has held it in 7 quarters since. The position peaked at $540K in Q1 2022. 65 funds tracked by Wall St. Rank hold LONA as of Q4 2023.

  • Potomac Capital Management held 14,959 shares of LeonaBio Inc worth $363K as of Q4 2023.
  • Potomac Capital Management bought 7,500 LeonaBio Inc shares in Q4 2023, an estimated $133K.
  • LeonaBio Inc made up 0.42% of Potomac Capital Management's portfolio in Q4 2023, its #42 holding.
  • Potomac Capital Management first reported a position in LeonaBio Inc in Q4 2021 and has held it in 7 quarters since.
  • Potomac Capital Management's LeonaBio Inc position peaked at $540K in Q1 2022.
  • 65 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2023.

Based on Potomac Capital Management's 13F filing for Q4 2023, filed 15 Feb 2024.